|1.||Stern, Peter J: 4 articles (03/2013 - 07/2006)|
|2.||Beckenbaugh, Robert D: 4 articles (02/2009 - 05/2006)|
|3.||Rizzo, Marco: 4 articles (02/2009 - 05/2006)|
|4.||Moran, Steven L: 3 articles (02/2009 - 05/2006)|
|5.||Hormel, Kirsten B: 3 articles (12/2007 - 05/2006)|
|6.||Tuttle, Harrison G: 2 articles (07/2007 - 07/2006)|
|7.||Krimmer, H: 2 articles (05/2005 - 02/2005)|
|8.||Kang, Seungcheol: 1 article (08/2015)|
|9.||Park, Soo-Sung: 1 article (08/2015)|
|10.||Paulos, R-G: 1 article (02/2014)|
05/01/2005 - "The recently developed pyrolytic carbon implants (Ascension Orthopedics, Austin, Texas) for replacing the PIP joint were evaluated retrospectively regarding range of motion, functionality, and relief of pain. "
03/01/2013 - "Pyrolytic carbon arthroplasties of the metacarpophalangeal joint resulted in satisfactory outcomes at average 4-year follow-up, with improved joint motion, good pain relief and satisfaction, and few complications. "
12/01/2007 - "Preliminary results suggest that pyrolytic carbon MCP joint arthroplasty provides good pain relief, patient satisfaction, and functional improvement in managing OA and select cases of RA. "
01/01/2007 - "Our 2-year minimum follow-up evaluation of pyrolytic carbon implant arthroplasty showed improved pain relief and good overall patient satisfaction. "
05/01/2005 - "The results of this study demonstrate that pyrolytic carbon implants reduce pain and are functionally superior to arthrodesis. "
01/01/2011 - "The evolution of metal valves has resulted in newer generations under clinical study that have more laminar flow (minimizing interaction with blood products) and improved pyrolytic carbon (minimizing infection and interaction with blood products). "
10/01/2007 - "Improvement of pyrolytic carbon physicochemical properties thus could lead to a reduction in valvular prosthetic infections."
01/01/1999 - "Technical aspects are evaluated, including extra-anatomical by-pass, infection risk, and proposed solutions when run-off problems occurred when placing a graft, concluding with modern guidances when using this material, such as endotheliation, cryopreserved artery grafts, polyurethane and pyrolytic carbon grafts, negatively charged grafts, biodegradation prosthesis, laboratory artery development, small diameter grafts and endovascular surgery."
10/01/1975 - "Strikingly promising results were obtained from adjuvant LTIC in 10 of 33 patients with undifferentiated cancers. "
10/01/1975 - "Resections for cancer in 425 patients over a 22 year period included 117 operations during a 10 year control period in which LTIC was not used and 308 during the LTIC test period. "
|4.||Lung Neoplasms (Lung Cancer)
07/01/1994 - "Unlike previous studies where fatigue-crack propagation data were obtained using through-thickness, long cracks (approximately 2-20 mm long), growing in conventional (e.g., compact-tension) samples, experiments were performed on physically small cracks (approximately 100-600 microns long), initiated on the surface of the pyrolytic-carbon coating to simulate reality. "
07/01/2000 - "Fatigue behavior of a pyrolytic carbon."
09/01/1996 - "Pyrolytic carbon has been used for mechanical heart valves as a thromboresistant, wear resistant, and fatigue resistant material. "
06/01/1996 - "The large sample size of the fatigue test gives a high statistical confidence in the intrinsic fatigue behavior of pyrolytic carbon, which has been demonstrated in over three million implants of the material in actual devices with an accumulated experience of over ten million patient years. "
06/01/1996 - "Fatigue of isotropic pyrolytic carbon used in mechanical heart valves."
|4.||Heart Valve Prosthesis
|5.||Prostheses and Implants (Prosthesis)